![Photo](/media/story/16985/thumbnail.jpg)
Article • Research
Device trial could benefit stroke patients
In the fast-evolving field of left atrial appendage closure a new study has delivered data that could benefit thousands of patients at risk of stroke. Led by Professor Martin Bergmann, head of Interventional Cardiology at Cardiologicum Hamburg in Germany, the EWOLUTION study was conducted to evaluate the Watchman Left Atrial Appendage (LAA) closure device from manufacturer Boston Scientific.